Comparison Chart Gilead Sciences, Inc.

GILD

US3755581036

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5d. change	Varia. Jan 1.	1-year change	5-years change	Capi.	ST	MT	LT
	GILEAD SCIENCES, INC.	Other Pharmaceuticals	-2.28%	-0.68%	+30.35%	+31.08%	+98.16%	149B

Market Closed - Nasdaq Other stock markets 16:00:00 2025-12-12 EST			5-day change	1st Jan Change
120.40 ^USD	-2.28%		-0.68%	+30.35%

12-12	Arcus Biosciences, Inc. Provides Update on Phase 3 Star-221 Study and Concentrates Its R&D Investment on Cas Datifan and Emerging Inflammation and Immunology Portfolio	CI
12-12	Arcus, Gilead to Discontinue Phase 3 Trial of Potential Cancer Treatment -- Update	DJ

Comparison Chart Gilead Sciences, Inc.

Equities

GILD

US3755581036

Pharmaceuticals

Compared values

Technical Rankings Surperformance